BioCurity has established an experienced Scientific and Medical Advisory Board, with some of the preeminent leaders in the fields of medical oncology and radiation therapy.
John Heymach, MD, PhD
University of Texas MD Anderson Cancer Center
Dr. Heymach is the Chair of Thoracic/Head and Neck Medical Oncology at the University of Texas MD Anderson Cancer Center. He holds the David Bruton Endowed Chair in Cancer Research. He serves as Clinical Lead in Phase I/II clinical trials testing novel therapies for lung cancer and serves as PI on numerous NIH grants. Dr. Heymach co-leads the Lung Cancer Moon Shot Program. He received his MD and PhD from Stanford University and completed his Internship and Residency completed at Brigham & Women’s Hospital/Dana Farber.
Dr. Ratain is Associate Director for Clinical Sciences at the Comprehensive Cancer Center, University of Chicago Medicine. He is an international leader in Phase I clinical trials, pharmacogenetics, clinical trial methodology and clinical pharmacology of marketed drugs. He also serves as Director at the Center for Personalized Therapeutics, Chief Hospital Pharmacologist, University of Chicago Medicine. Dr. Ratain received his medical degree from Yale University and completed his Internship and Residency at Johns Hopkins Medicine.
Dr. Shah is the Director of the Breast Radiation Oncology Department at the Cleveland Clinic. He is also the Associate Professor of the Cleveland Clinic Lerner College of Medicine. Dr. Shah research focuses on the research and implementation of techniques and methods for limiting short and long-term radiation therapy side effects. He has published over 120 peer-reviewed articles and book chapters. Dr. Shah received his
Medical degree from Northeast Ohio Medical University and completed his Internship and Residency at William Beaumont Hospital.